Citalopram Hydrobromide Solution
NDC Package 65862-074-24
Package Information
Citalopram Hydrobromide solution is citalopram oral solution, USP is indicated for the treatment of depression.The efficacy of citalopram oral solution, USP in the treatment of depression was established in 4 to 6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the DSM-III and DSM-III-R category of major depressive disorder (see CLINICAL PHARMACOLOGY).A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. This formulation utilizes a solution delivery system. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 65862-074 and is authorized under FDA application ANDA077812.
Identification & Billing
- RxCUI: 309313 - citalopram 10 MG in 5 mL Oral Solution
- RxCUI: 309313 - citalopram 2 MG/ML Oral Solution
- RxCUI: 309313 - citalopram (as citalopram hydrobromide) 2 MG/ML Oral Solution
- RxCUI: 309313 - citalopram 10 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65862 - Aurobindo Pharma Limited
- 65862-074 - Citalopram Hydrobromide
- 65862-074-24 - 240 mL in 1 BOTTLE
- 65862-074 - Citalopram Hydrobromide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65862-074-24 identifies a specific commercial package of 240 ml in 1 bottle of Citalopram Hydrobromide, a human prescription drug labeled by Aurobindo Pharma Limited. This solution is formulated for oral use and contains citalopram hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurobindo Pharma Limited on August 28, 2006. The current certification is valid through December 31, 2027.
How is this Aurobindo Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65862007424. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 240 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.